Ajinomoto Co Inc (ADR) ( (AJINY) ) has released its Q1 earnings. Here is a breakdown of the information Ajinomoto Co Inc (ADR) presented to its investors.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Ajinomoto Co., Inc. is a Japanese company listed on the Tokyo Stock Exchange, primarily engaged in the production of seasonings, frozen foods, and healthcare products, with a focus on leveraging its expertise in amino acids for various applications.
Ajinomoto Co., Inc. reported its financial results for the three months ending June 30, 2025, highlighting a slight decrease in sales but notable improvements in profitability metrics. The company experienced a 0.4% decline in sales compared to the previous year, totaling ¥364 billion, while business profit increased by 9.7% to ¥47.2 billion, and profit attributable to owners of the parent company rose by 34.4% to ¥32.2 billion.
The company’s Seasonings and Foods segment saw a slight decrease in sales due to currency translation effects, but business profit increased due to higher unit prices. The Frozen Foods segment faced a decline in both sales and business profit, impacted by currency translation and decreased sales in Japan. However, the Healthcare and Others segment showed strong performance with a 1.1% increase in sales and a significant 33.8% rise in business profit, driven by robust sales in electronic materials and Bio-Pharma Services.
Ajinomoto’s financial position as of June 30, 2025, showed an increase in total assets to ¥1,747.4 billion, with a notable rise in interest-bearing debt due to commercial paper issuance. The company maintained a healthy cash flow, with net cash provided by operating activities totaling ¥30.4 billion, despite increased investing activities.
Looking ahead, Ajinomoto Co., Inc. remains focused on its strategic goals, with management maintaining its financial forecast for the fiscal year ending March 31, 2026, projecting a 5.7% increase in sales and a 13% rise in business profit, reflecting confidence in its growth strategies and market position.